Petros Pharmaceuticals, Inc. (PTPI)
Q2-CY2026Q1-CY2026Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014
Balance Sheet Date2025-Dec-312025-Sep-302025-Jun-302025-Mar-312024-Dec-312024-Sep-302024-Jun-302024-Mar-312023-Dec-312023-Sep-302023-Jun-302023-Mar-312022-Dec-312022-Sep-302022-Jun-302022-Mar-312021-Dec-312021-Sep-302021-Jun-302021-Mar-31
Fiscal PeriodQ4-FY2025Q3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024Q3-FY2024Q2-FY2024Q1-FY2024Q4-FY2023Q3-FY2023Q2-FY2023Q1-FY2023Q4-FY2022Q3-FY2022Q2-FY2022Q1-FY2022Q4-FY2021Q3-FY2021Q2-FY2021Q1-FY2021
Total Assets5,163,598$6,133,468$7,396,843$17,605,366$10,635,310$20,693,630$25,169,274$30,312,335$33,795,795$38,914,168$28,727,108$30,570,428$32,421,214$37,696,443$51,049,941$55,864,147$67,390,058$52,035,328$56,670,244$66,154,008$69,854,014$
Total Current Assets5,163,598$6,133,468$7,396,843$14,465,646$7,294,278$10,724,480$13,979,045$17,902,455$20,390,396$24,433,180$13,150,892$13,903,466$14,667,905$18,771,620$22,853,237$26,838,105$30,542,695$13,354,324$16,234,052$23,963,664$25,905,053$
Cash and Cash Equivalents5,136,722$6,070,266$7,321,501$8,931,054$1,718,645$3,900,000$7,500,000$11,100,000$13,336,975$18,000,000$7,400,000$8,300,000$9,426,264$11,200,000$13,295,089$17,671,871$23,847,572$8,135,184$11,031,177$14,566,710$17,139,694$
Receivables
Other Current Assets6,532$4,760$86,547$81,079$111,476$57,563$31,743$71,743$138,226$141,587$129,734$75,542$110,167$612,673$136,360$97,083$114,784$
Assets Held for Sale in Short Term5,481,187$5,574,748$
Total Noncurrent Assets0$0$0$3,139,720$3,341,032$9,969,150$11,190,229$12,409,880$13,405,399$14,480,988$15,576,216$16,666,962$17,753,309$18,924,823$28,196,704$29,026,042$36,847,363$38,681,004$40,436,192$42,190,344$43,948,961$
Goodwill
Other Intangible Assets3,204,354$6,825,887$7,541,171$8,256,453$8,971,737$9,771,764$10,596,004$11,420,244$12,244,484$13,158,203$22,176,519$23,734,834$25,293,149$26,982,098$28,708,372$30,434,646$32,160,919$
Physical Assets22,948$18,819$23,846$26,402$28,957$31,513$34,067$36,622$39,177$41,732$44,287$46,842$49,397$51,952$54,507$57,062$64,250$
Other Noncurrent Assets294,391$326,921$358,472$389,080$475,557$529,056$554,379$579,535$
Assets Held for Sale in Long Term3,139,720$3,341,032$
Total Liabilities2,292,744$2,765,381$2,949,960$27,189,574$18,102,888$17,576,521$15,983,229$19,618,777$21,315,772$31,857,093$15,782,819$15,122,772$15,718,747$17,001,461$16,832,900$20,137,579$31,845,094$34,188,332$37,179,517$45,230,868$52,384,962$
Total Current Liabilities2,292,744$2,765,381$2,949,960$27,131,984$18,027,665$12,562,104$9,976,345$11,219,531$10,770,751$8,082,063$7,965,367$6,885,283$7,067,976$7,944,566$7,376,848$10,288,750$30,980,076$33,500,583$34,489,946$40,220,356$41,894,042$
Accounts Payable83,883$421,142$970,025$756,703$764,333$1,600,992$791,091$2,137,255$1,713,253$1,355,060$1,783,731$1,858,353$1,806,399$2,084,519$4,557,969$
Short Term Debt1,740,752$3,425,378$5,061,264$7,175,029$
Short Term Capital Lease Obligations62,433$125,022$148,758$152,780$147,480$142,340$137,596$133,462$129,458$125,579$121,589$117,256$113,052$108,971$
Other Current Liabilities135$448$225$1,300$941$224,465$51,883$225,110$297,428$441,431$777,448$232,814$409,796$73,072$308,311$474,762$131,662$225,514$398,504$618,479$178,381$
Total Noncurrent Liabilities0$0$0$57,590$75,223$5,014,417$6,006,884$8,399,246$10,545,021$23,775,030$7,817,452$8,237,489$8,650,771$9,056,895$9,456,052$9,848,829$865,018$687,749$2,689,571$5,010,512$10,490,920$
Long Term Debt
Long Term Capital Lease Obligations75,223$137,655$151,395$183,328$223,573$262,677$300,152$336,108$371,053$405,018$437,749$469,571$500,512$530,597$
Other Noncurrent Liabilities75,223$91,832$107,756$123,021$137,657$151,395$183,329$223,575$262,678$300,153$336,109$371,053$405,018$437,749$600,920$
Total Equity2,870,854$3,368,087$4,446,883$(9,584,208$)(7,467,578$)3,115,711$8,070,283$9,786,579$12,071,041$6,932,543$12,944,289$15,447,656$16,702,467$20,694,982$34,217,041$35,726,568$35,544,964$17,846,996$19,490,727$20,923,140$17,469,052$(7,128,734$)(3,828,371$)1,936,003$
Equity to Minority
Equity to Common Shareholders2,870,854$3,368,087$4,446,883$(9,584,208$)(7,467,578$)3,115,711$8,070,283$9,786,579$12,071,041$6,932,543$12,944,289$15,447,656$16,702,467$20,694,982$34,217,041$35,726,568$35,544,964$17,846,996$19,490,727$20,923,140$17,469,052$(7,128,734$)(3,828,371$)1,936,003$
Additional Paid-In Capital114,161,402$114,322,129$114,478,202$105,883,980$105,740,751$107,049,640$109,783,623$110,838,135$110,960,324$106,140,063$107,602,301$107,558,987$107,428,652$107,197,944$106,889,809$106,587,544$106,233,577$80,348,891$80,295,724$79,615,223$79,170,225$
Retained Earnings(111,294,776$)(110,958,270$)(110,035,547$)(115,468,393$)(113,208,371$)(103,934,931$)(101,714,270$)(101,052,244$)(98,889,581$)(99,207,731$)(94,658,223$)(92,111,540$)(90,726,393$)(86,505,033$)(72,674,836$)(70,863,044$)(70,688,820$)(62,502,878$)(60,805,980$)(58,693,063$)(61,702,144$)
Treasury Stock
Capital Lease Obligations137,656$262,677$300,153$336,108$371,053$405,017$437,748$469,570$500,511$530,597$559,338$586,827$613,564$639,568$